SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences informs about newspaper advertisements

27 Aug 2021 Evaluate

In furtherance to letter dated August 26, 2021, Eiko Lifesciences has informed that it attached copies of the advertisements published today in the Financial Express (in English) and Mumbai Lakshdeep (in Marathi) with respect to the notice of 44th Annual General Meeting of the Company scheduled to be held on September 28, 2021, at 4.30 pm through video conferencing/ Other Audio-Visual means, including remote e-voting details. Copy of the same is also uploaded on the website of the Company https://www.narendrainvestment.com.

The above information is a part of company’s filings submitted to BSE.



Eiko Lifesciences Share Price

50.25 -0.03 (-0.06%)
06-May-2026 14:28 View Price Chart
Peers
Company Name CMP
BASF India 3832.15
Tata Chemicals 814.30
SRF 2720.90
Pidilite Inds. 1419.00
Deepak Nitrite 1829.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×